N200 and P300 component changes in Parkinson's disease: a meta-analysis
Hui Xu1,2, Lihua Gu1,2, Shiyao Zhang1,2
1Department of Neurology, Affiliated ZhongDa Hospital of Southeast University, Nanjing, 210009, Jiangsu Province, China.
Summary
Event-related potential (ERP) components N200 and P300 may serve as biomarkers for early cognitive impairment in Parkinson's disease (PD). This meta-analysis reviewed ERP data, suggesting their potential for non-invasive clinical diagnosis in PD patients.
Area of Science:
- Neuroscience
- Clinical Neurology
Background:
- Cognitive impairment significantly impacts Parkinson's disease (PD) patients' quality of life.
- Existing research on event-related potential (ERP) components (N200, P300) and cognitive function in PD presents controversial findings.
- A meta-analysis is crucial to clarify the role of N200 and P300 in PD-related cognitive changes.
Purpose of the Study:
- To conduct a meta-analysis of N200 and P300 latency and amplitude data from event-related potential (ERP) studies in Parkinson's disease (PD).
- To compare ERP components among PD patients, PD dementia (PDD) patients, PD non-dementia (PDND) patients, and healthy controls (HC).
Main Methods:
- Systematic literature search of PubMed and Web of Science for PD-related ERP studies published before December 2021.
- Meta-analysis using standard mean difference (SMD) and 95% confidence intervals (CI) for N200 and P300 components.
- Comparison of ERP data across different patient groups (PD, PDD, PDND) and healthy controls.
Main Results:
- PD patients exhibited prolonged N200 latency at Fz and Cz electrodes and prolonged P300 latency at Fz compared to HC.
- PDND patients showed prolonged N200 latency at Cz and Pz electrodes compared to HC.
- PDD patients had prolonged P300 latency at Cz compared to PDND patients, and PDND patients displayed reduced P300 amplitude at Fz compared to HC.
Conclusions:
- N200 and P300 components show potential as electrophysiological biomarkers for early cognitive impairment in PD.
- These ERP components could aid clinicians in diagnosing early cognitive impairment in PD due to their non-invasive nature.
- Further research is necessary to validate these findings and confirm the diagnostic utility of N200 and P300 in PD.
Related Concept Videos
01:24Parkinson's Disease: Treatment
361
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
361
01:15Parkinson's Disease: Overview
684
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
684
01:37Neural Regulation
39.7K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.7K